Ivan Mishanin
About Ivan Mishanin
Ivan Mishanin is the COO and co-founder of Brainify.AI, where he focuses on AI and machine learning innovations in psychiatric drug development. With over 20 years of experience in technology and a background in business development, he has held key positions at Bright Box and incadea GmbH, and has a strong commitment to advancing mental health care.
Current Role at Brainify.AI
Ivan Mishanin serves as the Chief Operating Officer and co-founder of Brainify.AI, a position he has held since 2021. In this role, he focuses on leveraging artificial intelligence and machine learning to innovate drug development for psychiatric disorders. His work at Brainify.AI reflects his commitment to advancing technology in the field of neuroscience, aiming to improve mental health care solutions.
Previous Experience at Bright Box
Before joining Brainify.AI, Ivan Mishanin was the Chief Executive Officer of Bright Box from 2012 to 2021. During his nine years at Bright Box, he played a crucial role in the company's growth and strategic direction. His leadership culminated in the successful acquisition of Bright Box by Zurich Insurance Group, demonstrating his capability in steering companies towards successful exits.
Professional Background in Business Development
Ivan Mishanin has extensive experience in business development, having worked as the Business Development Director at incadea GmbH from 2008 to 2012. His role involved managing portal and mobile solutions while operating in diverse international markets, including Asia, the Middle East, Europe, and the USA. Additionally, he held a position as a Business Development Manager at Columbus IT for a brief period in 2008.
Education and Training at Harvard Business School
Ivan Mishanin studied at Harvard Business School, where he pursued a program in Business Administration and Management, achieving the Program for Leadership Development Award (PLDA) from 2023 to 2024. His education at Harvard has contributed to his strategic thinking and leadership capabilities in the tech industry.
Involvement in Innovation and Mental Health Care
Ivan Mishanin is actively involved in transforming drug development for psychiatric disorders through AI and machine learning innovation at Brainify.AI. His personal experience with depression motivates his commitment to enhancing mental health care solutions, reflecting his dedication to high-tech ventures in neuroscience.